Trial intelligence / Profile preview

Insulin Aspart Before vs After Meal in Type 1 Diabetes

NCT02546401Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Sep 2015
Primary completion
Mar 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), sponsored by Centre Hospitalier Universitaire de Brest. Started Sep 2015; status: completed.

02

Drugs

insulin aspart
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT02546401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02546401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call